XML 121 R103.htm IDEA: XBRL DOCUMENT v3.22.0.1
Segment and Geographic Information - Schedule of Customer Concentration by Collaboration Partners and Distribution Entity (Detail) - Customer Concentration Risk [Member]
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Percentage of Revenue [Member] | Astellas-Related party [Member]      
Entity Wide Revenue Major Customer [Line Items]      
Concentration risk, percentage 57.00% 21.00% 48.00%
Percentage of Revenue [Member] | AstraZeneca [Member]      
Entity Wide Revenue Major Customer [Line Items]      
Concentration risk, percentage 20.00% 37.00% 52.00%
Percentage of Revenue [Member] | Falikang—Related party      
Entity Wide Revenue Major Customer [Line Items]      
Concentration risk, percentage 15.00% 0.00% 0.00%
Percentage of Accounts Receivable [Member] | Astellas-Related party [Member]      
Entity Wide Revenue Major Customer [Line Items]      
Concentration risk, percentage 63.00% 10.00%  
Percentage of Accounts Receivable [Member] | AstraZeneca [Member]      
Entity Wide Revenue Major Customer [Line Items]      
Concentration risk, percentage 34.00% 26.00%  
Percentage of Accounts Receivable [Member] | Falikang—Related party      
Entity Wide Revenue Major Customer [Line Items]      
Concentration risk, percentage 0.00% 0.00%